Sector ratings Chugai Pharmaceutical Co., Ltd.

Equities

Delayed Japan Exchange Other stock markets 06:30:00 16/01/2026 GMT			5-day change	1st Jan Change
8,252.00 ^JPY	-3.98%		-2.01%	+0.11%

12-30	Chugai Completes Merger With Renalys Pharma	MT
12-29	Chugai Pharmaceutical Co., Ltd. completed the acquisition of Renalys Pharma.	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
CHUGAI PHARMACEUTICAL CO., LTD.	89.25B		AA
ELI LILLY AND COMPANY	925B		A
JOHNSON & JOHNSON	529B		BBB
ABBVIE INC.	383B		AA
ROCHE HOLDING AG	368B		AA
ASTRAZENECA PLC	291B		A
NOVARTIS AG	274B		AAA
MERCK & CO., INC.	275B		A
NOVO NORDISK A/S	252B		A
AMGEN INC.	178B		A
GILEAD SCIENCES, INC.	150B		AAA
PFIZER INC.	147B		BBB
SANOFI	115B		A
BRISTOL-MYERS SQUIBB COMPANY	115B		A
VERTEX PHARMACEUTICALS INCORPORATED	111B		AA
GSK PLC	99.28B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	60.31B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	51.6B		AA
ALNYLAM PHARMACEUTICALS, INC.	47.46B		AA	-
Average	226.29B		AA
Weighted average by Cap.			AA